Location History:
- Ulm, DE (2003 - 2013)
- Neu-Ulm, DE (2012 - 2015)
Company Filing History:
8 out of 194 
3 out of 276 
2 out of 1,535 
Years Active: 2003-2015
Title: Innovative Contributions of Martin Lenter in Biomedical Research
Introduction: Martin Lenter, based in Ulm, Germany, is a prominent inventor with a remarkable portfolio of 13 patents. His work primarily revolves around medical innovations, particularly in the fields of neurodegenerative diseases and metabolic disorders. Lenter's inventions have significant implications for treating conditions like Alzheimer's disease and various metabolic syndromes.
Latest Patents: Among Lenter's latest patents are notable inventions such as "A-beta binding polypeptides," which focus on biparatopic A-beta binding polypeptides. This invention explores polypeptides that possess at least two immunoglobulin single variable domains that bind to different epitopes of A-beta. The potential applications of this innovation include methods of production and treatment options for diseases, most prominently Alzheimer's disease.
Another significant patent is related to "alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds." This invention defines alkyne compounds that show antagonistic activity towards MCH-receptors, making them suitable for treating a variety of metabolic disorders, including obesity, bulimia, anorexia, hyperphagia, and diabetes.
Career Highlights: Lenter has gained extensive experience through his work at prestigious organizations. He has contributed significantly to the pharmaceutical sector while being associated with Boehringer Ingelheim Pharma GmbH & Co. KG and Boehringer Ingelheim Pharmaceuticals, Inc. His role within these companies has allowed him to turn innovative ideas into viable products.
Collaborations: Throughout his career, Martin Lenter has collaborated with esteemed colleagues, including Walter Spevak and Gerald Juergen Roth. These collaborations have fostered an environment of innovation and have led to successful research outcomes that benefit the medical community.
Conclusion: Martin Lenter's contributions to biomedical research are invaluable, backed by a strong foundation of patented innovations. His work continues to pave the way for the development of novel therapeutics aimed at treating complex diseases such as Alzheimer's and various metabolic disorders, solidifying his reputation as a leading inventor in the pharmaceutical industry.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.